Yearly Archives: 2020

Congress Nears Deal on COVID-19 Stimulus Package

By Denise Bell | Published December 18, 2020

Leaders of both parties inched closer on Thursday to agreement on a COVID-19 stimulus package. The package would include more funding for PPP loans, allow a second loan draw for hard-hit small businesses and streamline forgiveness for loans of $150,000 or less. In addition, the measure is expected to include some level of direct payments […]

Posted in COVID-19 Legislation, COVID-19 Updates, Policy News | Leave a comment

IONIQ Sciences Designated ‘Most Innovative Cancer Detection and Diagnostics Technology Firm’ by CV Magazine

By admin | Published December 14, 2020

12/10/2020 – IONIQ Sciences has been designated as 2020’s ‘Most Innovative Cancer Detection and Diagnostics Technology Firm’ by CV Magazine. Our goal to modernize cancer testing has taken us to exciting heights this year. We resolutely believe in our potential to introduce a ‘breakthrough’ Multi-Cancer Screen that will non-invasively detect the presence of malignancy in its earliest stages utilizing our Electrical Impedance Analytics […]

Posted in Industry News, Life Sciences Industry News | Leave a comment

SDP Oncology Presents Data Evaluating Alvocidib in Patients with Acute Myeloid Leukemia and Other Updates on Development Programs at ASH 2020

By Denise Bell | Published December 11, 2020

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new data from the Phase 2 Zella 201 study evaluating the investigational agent alvocidib, a potent CDK9 inhibitor, in patients with MCL-1 dependent acute myeloid leukemia (AML). These results were presented at the 62nd American Society of Hematology Annual Meeting, which was held virtually December 5-8, […]

Posted in BioUtah News | Leave a comment

Utah Readies to Receive 154,000 COVID-19 Vaccines

By Denise Bell | Published December 11, 2020

Governor Herbert yesterday announced that teachers would move up to the front of the line for the COVID-19 vaccine. In addition to teachers, the first phase of vaccinations in Utah will focus on healthcare workers, as well as residents and staff of long-term care facilities. Last week, BioUtah sent a letter to the Utah Department […]

Posted in COVID-19 Updates, Feature, State News | Leave a comment

Drug Industry Trade Groups File Lawsuits on Most-Favored-Nation Pricing Rule

By Denise Bell | Published December 11, 2020

The Trump administration recently announced an interim final rule to implement the Most Favored Nation drug pricing model, which would tie prices of certain Medicare Part B drugs to the lowest prices paid in Organisation for Economic Cooperation and Development (OECD) countries. In response, drug industry trade groups have filed two lawsuits against the administration on December […]

Posted in Policy News | Leave a comment

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in the Dubermatinib Arm of The Leukemia & Lymphoma Society’s Beat AML Master Clinical Trial in Patients with Acute Myeloid Leukemia

By admin | Published December 10, 2020

Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced the first patient has been dosed in a Phase 1b/2 study evaluating the oral investigational agent, dubermatinib (TP-0903), an AXL kinase inhibitor, in combination with decitabine, in patients 60 years or older with newly diagnosed acute myeloid leukemia (AML) who have TP53 […]

Posted in BioUtah News, Industry News, Life Sciences Industry News | Leave a comment

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 2 of Cancer Study

By admin | Published December 10, 2020

Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced the first patient has been dosed in the Phase 2 expansion portion of the study evaluating DSP-7888, an investigational immunotherapeutic cancer vaccine that targets Wilms Tumor 1 (WT1), in combination with checkpoint inhibitor pembrolizumab, in patients with platinum-resistant ovarian cancer (PROC). The […]

Posted in BioUtah News, Industry News, Life Sciences Industry News | Leave a comment